Exploring the transformability of polymer-lipid hybrid nanoparticles and nanomaterial-biology interplay to facilitate tumor penetration, cellular uptake and intracellular targeting of anticancer drugs-Reference-Cited by-同舟云学术

Exploring the transformability of polymer-lipid hybrid nanoparticles and nanomaterial-biology interplay to facilitate tumor penetration, cellular uptake and intracellular targeting of anticancer drugs

Published:2021-03-30 Issue: Volume: Page:1-14
ISSN:1742-5247
Container-title:Expert Opinion on Drug Delivery
language:en
Short-container-title:Expert Opinion on Drug Delivery

Author:

Amini Mohammad Ali¹,Ahmed Taksim¹,Liu Fuh-Ching Franky¹,Abbasi Azhar Z.¹,Soeandy Chesarahmia Dojo¹,Zhang Rui Xue¹,Prashad Preethy¹,Cummins Carolyn L.²,Rauth Andrew M.³,Henderson Jeffrey T.¹,Wu Xiao Yu¹

Affiliation:

1. Advanced Pharmaceutics & Drug Delivery Laboratory, Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Ontario, Canada

2. Department of Pharmaceutical Sciences, Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Ontario, Canada

3. Departments of Medical Biophysics and Radiation Oncology, University of Toronto, Princess Margaret Cancer Centre, 610 University Avenue, Toronto, Ontario, Canada.

Publisher

Informa UK Limited

Subject

Pharmaceutical Science

Link

https://www.tandfonline.com/doi/pdf/10.1080/17425247.2021.1902984

Reference62 articles.

1. Cancer nanomedicine: progress, challenges and opportunities

2. Nanoparticle Delivery of Cancer Drugs

3. Design of nanocarriers for nanoscale drug delivery to enhance cancer treatment using hybrid polymer and lipid building blocks

4. Nanomedicine of synergistic drug combinations for cancer therapy – Strategies and perspectives

5. Intelligent nanoparticles for advanced drug delivery in cancer treatment

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting DNA damage repair mechanism by using RAD50-silencing siRNA nanoparticles to enhance radiotherapy in triple negative breast cancer;Materials Today Bio;2024-10

2. Rational design of solid lipid-polymer hybrid nanoparticles: An innovative glycoalkaloids-carrier with potential for topical melanoma treatment;Colloids and Surfaces B: Biointerfaces;2024-10

3. An update on strategies for optimizing polymer-lipid hybrid nanoparticle-mediated drug delivery: exploiting transformability and bioactivity of PLN and harnessing intracellular lipid transport mechanism;Expert Opinion on Drug Delivery;2024-02

4. Lipid-based nanoparticles to address the limitations of GBM therapy by overcoming the blood-brain barrier, targeting glioblastoma stem cells, and counteracting the immunosuppressive tumor microenvironment;Biomedicine & Pharmacotherapy;2024-02

5. Corrigendum to “Quantitative comparison of the protein corona of nanoparticles with different matrices” [Int J Pharm X 2022 Oct 21;4: 100136];International Journal of Pharmaceutics: X;2023-12